PATENT CLAIM ANALYSIS

Application Number: 15933215
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "030000"]

Abstract:
This disclosure provides methods for the treatment of one or more of: Parkinson's disease (PD); PD symptoms; movement disorders; neurodegenerative diseases linked to changes in dopamine, dopamine signaling, or dopamine expression, in a subject in need thereof comprising administering to the subject an effective amount of an agent that potentiates dopaminergic neurotransmission. Also provided is a method for selecting a candidate agent for the treatment of Parkinson's disease (PD); PD symptoms; and neurodegenerative diseases linked to changes in dopamine, dopamine signaling, or dopamine expression.

Claim (Index 3):
The method of  claim 1 , wherein the neurodegenerative diseases linked to changes in dopamine are selected from the group of: encephalitis, concussions, dopamine-responsive dystonia, and Parkinsonian syndrome.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 90.0
- Lexical Diversity: 1.90741
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11460046', '15310364', '11479173', '10285308', '11631729']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7896405323956041
- 35 USC 102 Novelty (BERT): 0.5115161491245519
- Combined Prediction Score: 0.7618280940684989
- Mean Citation Score: 282.752272
- Max Citation Score: 294.6009
- Similarity Product: 226.1830792428732

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test